Soluble protein oligomers as emerging toxins in Alzheimer's and other amyloid diseases
- PMID: 17505973
- DOI: 10.1080/15216540701283882
Soluble protein oligomers as emerging toxins in Alzheimer's and other amyloid diseases
Abstract
Amyloid diseases are a group of degenerative disorders characterized by cell/tissue damage caused by toxic protein aggregates. Abnormal production, processing and/or clearance of misfolded proteins or peptides may lead to their accumulation and to the formation of amyloid aggregates. Early histopathological investigation of affected organs in different amyloid diseases revealed the ubiquitous presence of fibrillar protein aggregates forming large deposits known as amyloid plaques. Further in vitro biochemical and cell biology studies, as well as studies using transgenic animal models, provided strong support to what initially seemed to be a solid concept, namely that amyloid fibrils played crucial roles in amyloid pathogenesis. However, recent studies describing tissue-specific accumulation of soluble protein oligomers and their strong impact on cell function have challenged the fibril hypothesis and led to the emergence of a new view: Fibrils are not the only toxins derived from amyloidogenic proteins and, quite possibly, not the most important ones with respect to disease etiology. Here, we review some of the recent findings and concepts in this rapidly developing field, with emphasis on the involvement of soluble oligomers of the amyloid-beta peptide in the pathogenesis of Alzheimer's disease. Recent studies suggesting that soluble oligomers from different proteins may share common mechanisms of cytotoxicity are also discussed. Increased understanding of the cellular toxic mechanisms triggered by protein oligomers may lead to the development of rational, effective treatments for amyloid disorders.
Similar articles
-
Soluble oligomers from a non-disease related protein mimic Abeta-induced tau hyperphosphorylation and neurodegeneration.J Neurochem. 2007 Oct;103(2):736-48. doi: 10.1111/j.1471-4159.2007.04809.x. Epub 2007 Aug 28. J Neurochem. 2007. PMID: 17727639
-
Protein denaturation and aggregation: Cellular responses to denatured and aggregated proteins.Ann N Y Acad Sci. 2005 Dec;1066:181-221. doi: 10.1196/annals.1363.030. Ann N Y Acad Sci. 2005. PMID: 16533927 Review.
-
Soluble amyloid beta oligomers may contribute to apoptosis of retinal ganglion cells in glaucoma.Med Hypotheses. 2008;71(1):77-80. doi: 10.1016/j.mehy.2008.01.030. Epub 2008 Apr 11. Med Hypotheses. 2008. PMID: 18406539
-
Conformation-dependent anti-amyloid oligomer antibodies.Methods Enzymol. 2006;413:326-44. doi: 10.1016/S0076-6879(06)13017-7. Methods Enzymol. 2006. PMID: 17046404
-
Common mechanisms of amyloid oligomer pathogenesis in degenerative disease.Neurobiol Aging. 2006 Apr;27(4):570-5. doi: 10.1016/j.neurobiolaging.2005.04.017. Epub 2006 Feb 14. Neurobiol Aging. 2006. PMID: 16481071 Review.
Cited by
-
Characterizing affinity epitopes between prion protein and β-amyloid using an epitope mapping immunoassay.Exp Mol Med. 2013 Aug 2;45(8):e34. doi: 10.1038/emm.2013.63. Exp Mol Med. 2013. PMID: 23907583 Free PMC article.
-
Modulation of MicroRNAs as a Potential Molecular Mechanism Involved in the Beneficial Actions of Physical Exercise in Alzheimer Disease.Int J Mol Sci. 2020 Jul 14;21(14):4977. doi: 10.3390/ijms21144977. Int J Mol Sci. 2020. PMID: 32674523 Free PMC article. Review.
-
An Essential Role for Alzheimer's-Linked Amyloid Beta Oligomers in Neurodevelopment: Transient Expression of Multiple Proteoforms during Retina Histogenesis.Int J Mol Sci. 2022 Feb 17;23(4):2208. doi: 10.3390/ijms23042208. Int J Mol Sci. 2022. PMID: 35216328 Free PMC article.
-
Amyloid-beta peptide oligomers disrupt axonal transport through an NMDA receptor-dependent mechanism that is mediated by glycogen synthase kinase 3beta in primary cultured hippocampal neurons.J Neurosci. 2010 Jul 7;30(27):9166-71. doi: 10.1523/JNEUROSCI.1074-10.2010. J Neurosci. 2010. PMID: 20610750 Free PMC article.
-
Do amyloid oligomers act as traps for misfolded proteins? A hypothesis.Amyloid. 2008 Sep;15(3):160-5. doi: 10.1080/13506120802193746. Amyloid. 2008. PMID: 18925454 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical